Hormone therapy combined with tirzepatide linked to greater weight loss after menopause

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the treatment of overweight and obesity. The…

Continue Reading

News Source: medicalxpress.com